Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-04-02 Sale |
2025-04-04 8:01 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
3,860 | $36.22 | $139,801 | 247,173 (Direct) |
View |
2025-03-05 Sale |
2025-03-07 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,590 | $30.48 | $48,463 | 251,033 (Direct) |
View |
2025-02-05 Sale |
2025-02-07 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
3,520 | $40.69 | $143,229 | 423,998 (Direct) |
View |
2025-01-02 Sale |
2025-01-03 8:00 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
4,085 | $46.94 | $191,740 | 427,518 (Direct) |
View |
2024-12-11 Sale |
2024-12-13 8:01 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
4,540 | $48.76 | $221,363 | 431,603 (Direct) |
View |
2024-12-04 Sale |
2024-12-06 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
6,665 | $46.07 | $307,057 | 260,798 (Direct) |
View |
2024-11-06 Sale |
2024-11-08 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
6,665 | $59.12 | $394,041 | 267,463 (Direct) |
View |
2024-10-02 Sale |
2024-10-04 8:02 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
6,665 | $56.26 | $374,954 | 274,128 (Direct) |
View |
2024-09-04 Sale |
2024-09-06 8:03 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
6,665 | $47.56 | $316,969 | 280,793 (Direct) |
View |
2024-08-07 Sale |
2024-08-09 8:05 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
7,335 | $40.67 | $298,336 | 287,458 (Direct) |
View |
2024-07-03 Sale |
2024-07-05 8:01 pm |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
5,995 | $37.6 | $225,418 | 294,793 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-05 Exercise |
2025-02-07 8:02 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
795 | $22.86 | 423,998 (Direct) |
View |
2025-02-05 Exercise |
2025-02-07 8:02 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
795 | $0 | 423,998 (Direct) |
View |
2025-01-02 Exercise |
2025-01-03 8:00 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,360 | $22.86 | 427,518 (Direct) |
View |
2025-01-02 Exercise |
2025-01-03 8:00 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,360 | $0 | 427,518 (Direct) |
View |
2024-12-11 Exercise |
2024-12-13 8:01 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,815 | $22.86 | 431,603 (Direct) |
View |
2024-12-11 Exercise |
2024-12-13 8:01 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
1,815 | $0 | 431,603 (Direct) |
View |
2024-12-09 Option Award |
2024-12-11 8:01 pm |
N/A 2034-12-09 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
124,962 | $0 | 124,962 (Direct) |
View |
Ownership |
2024-09-06 5:05 pm |
N/A 2024-05-06 |
Oruka Therapeutics Inc. | ORKA | Dambkowski Carl Director |
0 | $0 | 94,282 (Direct) |
View |
2023-12-18 Option Award |
2023-12-20 8:01 pm |
N/A 2033-12-18 |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
175,345 | $0 | 175,345 (Direct) |
View |
Ownership(A) |
2023-07-17 5:06 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
0 | $0 | 300,788 (Direct) |
View |
Ownership |
2023-07-13 6:42 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer |
0 | $0 | 279,105 (Direct) |
View |